Majlen Dilweg
Promovendus
- Naam
- M.A. Dilweg MSc
- Telefoon
- +31 71 527 4324
- m.a.dilweg@lacdr.leidenuniv.nl
- ORCID iD
- 0000-0002-4455-3737
For more information look at the English website
Promovendus
- Wiskunde en Natuurwetenschappen
- Leiden Academic Centre for Drug Research
- LACDR/Medicinal Chemistry
- Veggel L. van: Mocking TA.M.: Sijben H.J.: Liu R.: Gorostiola González M.: Dilweg M.A.: Royakkers J.: Li A.: Kumar V.: Dong Y.Y.: Bullock A.: Sauer D.B.: Diliën H.: Westen G.J.P. van: Schreiber R.: Heitman L.H.: Vanmierlo T. (2024), Still in search for an EAAT activator: GT949 does not activate EAAT2, nor EAAT3 in impedance and radioligand uptake assays, ACS Chemical Neuroscience 15(7): 1424-1431.
- Wang X. Jespers W. Bongers B.J. Habben Jansen M.C.C. Stangenberger C.M. Dilweg M.A. Gutiérrez-de-Terán H. IJzerman A.P. Heitman L.H. Westen G.J.P. van (2020), Characterization of cancer-related somatic mutations in the adenosine A2B receptor, European Journal of Pharmacology 880: 173126.
- Yang X. Dilweg M.A. Osemwengie D. Burggraaff L. Es D. van der Heitman L.H. IJzerman A.P. (2020), Design and pharmacological profile of a novel covalent partial agonist for the adenosine A1 receptor, Biochemical Pharmacology 180: 114144.